Core Insights - Option Care Health reported a net revenue of $1,227.2 million for Q2 2024, representing a 14.8% increase from $1,069.1 million in Q2 2023 [11] - The company experienced a net income of $53.0 million, or $0.30 diluted earnings per share, which is a 53.6% decrease compared to $114.4 million, or $0.63 diluted earnings per share, in the same quarter last year [11] - Adjusted EBITDA for Q2 2024 was $108.4 million, down 1.5% from $110.1 million in Q2 2023 [11] Financial Performance - Gross profit for Q2 2024 was $249.4 million, accounting for 20.3% of net revenue, slightly down from $250.8 million, or 23.5% of net revenue, in Q2 2023 [11] - Cash flow from operations increased to $195.7 million from $169.5 million in Q2 2023 [11] - The company repurchased approximately $78.1 million of stock during the quarter [11] Balance Sheet Highlights - Total assets as of June 30, 2024, were $3,348.6 million, up from $3,217.0 million at the end of 2023 [8] - Current assets increased to $1,227.4 million from $1,094.3 million at the end of 2023 [8] - Total liabilities rose to $1,937.2 million from $1,795.4 million at the end of 2023 [8] Guidance for Full Year 2024 - The company expects net revenue to be between $4.75 billion and $4.85 billion [23] - Adjusted EBITDA is projected to be between $435 million and $450 million [23] - Cash flow from operations is anticipated to be at least $300 million, consistent with previous guidance [23]

BANNOCKBURN, IL., July 31, 2024 - Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Note that the second quarter of 2023 net income and cash flow from operations includes $62.8 million related to the termination payment received on behalf of Amedisys, net of merger-related expenses and taxes. Conference Call OPTIO ...

Conference Call Details About Option Care Health For Investor Inquiries: BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results ...

BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants ...

In the U.S. alone, national health expenditure is expected to increase annually from 2023 and 2032, according to the Centers for Medicare & Medicaid Services. So, profit is to be had in medicine — but only if you move fast enough. A Strong Buy rating from analysts Positive revenue and net income growth in its last annual report Trades above $10 Vericel (VCEL) Vericel (NASDAQ:VCEL) specializes in severe burns and sports medicines in the United States. The company has three main products: The company previous ...

Option Care (OPCH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices - - has triggered this rating change. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Since a changing ...

BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Webcast links and related presentation materials will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation's largest independent provider of home and alternate site in ...

Option Care (OPCH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earni ...

Financial Performance - For the three months ended March 31, 2024, net revenue increased to $1,146,052, representing a 12.8% growth compared to $1,015,848 in the same period of 2023[87] - Gross profit for the first quarter of 2024 was $238,500, with a gross profit margin of 20.8%, down from 22.5% in the prior year[89] - Operating income for the first quarter of 2024 was $69,030, which is 6.0% of revenue, compared to $66,625 or 6.6% of revenue in the same quarter of 2023[87] - Net income for the three months ended March 31, 2024, was $44.8 million, an increase of 14.2% from $39.2 million in the same period of 2023[93] - Net comprehensive income rose to $46.3 million for the three months ended March 31, 2024, compared to $35.8 million for the same period in 2023, reflecting a 29.6% increase[94] Expenses and Costs - Selling, general and administrative expenses increased to $154,742, but as a percentage of revenue, they decreased to 13.5% from 14.6% year-over-year[90] - Total operating expenses for Q1 2024 were $169,470, compared to $162,380 in Q1 2023, reflecting a 4.4% increase[90] - Interest expense, net decreased to $13,202 in Q1 2024 from $13,834 in Q1 2023, reflecting a 4.6% reduction[91] - Income tax expense for the first quarter of 2024 was $12,164, down 19.0% from $15,021 in the same quarter of 2023, with an effective tax rate of 21.4%[92] Cash Flow and Liquidity - Cash and cash equivalents decreased to $219.5 million as of March 31, 2024, down from $343.8 million at the end of 2023[96] - Cash flows from operating activities showed a net cash outflow of $68.8 million for the three months ended March 31, 2024, compared to an inflow of $89.8 million in the same period of 2023, a variance of $158.5 million[106] - The company utilized $40.0 million for common stock repurchases during the three months ended March 31, 2024, compared to $75.0 million in the same period of 2023[109] - The company had $394.7 million of borrowings available under its credit facilities as of March 31, 2024[101] - The company’s cash flows from operations were impacted by the Change Healthcare Cybersecurity Incident, affecting accounts receivable[107] Strategic Initiatives - The increase in net revenue was primarily driven by organic growth in the company's portfolio of therapies, with chronic revenue growing in the mid-teens[89] - The company maintained strong liquidity and resumed claims submission to payers following the Change Healthcare Cybersecurity Incident, which did not materially impact financial results[74] - The company continues to work through accumulated unprocessed claims and establish full recovery with Change Healthcare's applications[73] - The company plans to continue evaluating acquisition opportunities as a key part of its growth strategy[98] - The company’s capital expenditures increased during the three months ended March 31, 2024, compared to the same period in 2023[108] - Interest payments on long-term debt obligations are estimated to total $341.8 million based on current rates as of March 31, 2024[104]

Option Care (OPCH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.18%. A quarter ago, it was expected that this infusion and home care services company would post earnings of $0.29 per share when it actually produced earnings of $0.32, delivering a surprise of 10.34%.Over the last ...